1.
Lichtenfels M, Frasson AL, Marcolin JC, Rezende H, Silva CA da, Souza ABA de, et al. Innovative platform for chemoresistance: advancing functional precision medicine in breast cancer. MAST [Internet]. 2026 Feb. 24 [cited 2026 Apr. 18];35(suppl.1). Available from: https://mastology.org/journal/article/view/1165